Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,766,960
-
Total 13F shares
-
14,848,153
-
Share change
-
+982,538
-
Total reported value
-
$3,429,412,203
-
Put/Call ratio
-
88%
-
Price per share
-
$231.00
-
Number of holders
-
208
-
Value change
-
+$220,213,706
-
Number of buys
-
121
-
Number of sells
-
104
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q2 2023
As of 30 Jun 2023,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by
208 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,848,153 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Assenagon Asset Management S.A., MARSHALL WACE, LLP, ALLIANCEBERNSTEIN L.P., and PAULSON & CO. INC..
This page lists
208
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.